MX2016014868A - Metodos para secar por congelacion y rehidratar productos biologicos. - Google Patents

Metodos para secar por congelacion y rehidratar productos biologicos.

Info

Publication number
MX2016014868A
MX2016014868A MX2016014868A MX2016014868A MX2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A MX 2016014868 A MX2016014868 A MX 2016014868A
Authority
MX
Mexico
Prior art keywords
methods
freeze
cells
drying
rehydrating
Prior art date
Application number
MX2016014868A
Other languages
English (en)
Inventor
Christophe Audonnet Jean-
Yves Henri Jean Genin Noel
Roy Didier
Seche Edouard
Gervais Patrick
KHALDI-PLASSART Samira
Useo Romain
De Coninck Joëlle
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2016014868A publication Critical patent/MX2016014868A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se relaciona generalmente a los campos de inmunología y tecnología de vacunas. Más específicamente, la presente invención se relaciona a métodos para secar por congelación preparaciones biológicas, que incluyen péptidos, antígenos, anticuerpos, y especialmente, células. De manera importante, los métodos descritos preservan la viabilidad, infectividad e inmunogenicidad de células de la Apicomplexa phylum, la familia Sarcocystidae, y en particular, células del género Toxoplasma.
MX2016014868A 2014-05-14 2015-05-13 Metodos para secar por congelacion y rehidratar productos biologicos. MX2016014868A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14168327 2014-05-14
PCT/US2015/030588 WO2015175672A1 (en) 2014-05-14 2015-05-13 Methods for freeze-drying and rehydrating biologics

Publications (1)

Publication Number Publication Date
MX2016014868A true MX2016014868A (es) 2017-07-19

Family

ID=50771060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016014868A MX2016014868A (es) 2014-05-14 2015-05-13 Metodos para secar por congelacion y rehidratar productos biologicos.

Country Status (7)

Country Link
US (1) US10632182B2 (es)
EP (1) EP3142486A1 (es)
AU (2) AU2015259221B2 (es)
CA (1) CA2948845C (es)
MX (1) MX2016014868A (es)
NZ (2) NZ741421A (es)
WO (1) WO2015175672A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3154338B1 (en) 2014-06-10 2020-01-29 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
JP6827048B2 (ja) 2015-12-08 2021-02-10 バイオマトリカ，インク． 赤血球沈降速度の低下
CN106047812B (zh) * 2016-05-25 2018-08-03 上海赛立维生物科技有限公司 肿瘤组织冻存、复苏试剂盒及其处理方法
CN109789097B (zh) * 2016-10-05 2021-05-18 硕腾服务有限责任公司 提供用作强效活疫苗的稳定脱水的原生动物的冻干方法
CN110072989A (zh) * 2016-10-24 2019-07-30 生物马特里卡公司 核酸在纸上的稳定化
MX2021001479A (es) * 2018-08-07 2021-04-28 Glaxosmithkline Biologicals Sa Novedosos procesos y vacunas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3783098A (en) 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US3915794A (en) 1973-02-09 1975-10-28 Rit Rech Ind Therapeut Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them
US4000256A (en) 1975-04-30 1976-12-28 Merck & Co., Inc. Varicella vaccine and process for its preparation
AU1415992A (en) 1991-02-15 1992-09-15 Cryopharm Corporation Method of lyophilization and reconstitution of mixtures of nucleated non-mammalian cells and blood matter
EP0826063A1 (en) 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
FR2775601B1 (fr) 1998-03-03 2001-09-21 Merial Sas Vaccins vivants recombines et adjuves
US6017537A (en) 1998-12-18 2000-01-25 Connaught Laboratories, Inc. Formyl methionyl peptide vaccine adjuvant
FR2864966B1 (fr) 2004-01-13 2006-05-05 Agronomique Inst Nat Rech Souches vaccinales d'apicomplexes de la famille des sarcocystidae.
JP5270925B2 (ja) 2008-02-07 2013-08-21 雪印メグミルク株式会社 微生物保護剤及び微生物の凍結又は凍結乾燥菌体の製造方法
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
US20110262965A1 (en) * 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
LT2603100T (lt) * 2010-08-13 2018-07-25 Advanced Bionutrition Corp. Stabilizuojanti kompozicija, skirta biologinių medžiagų sausam saugojimui
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
FR2994193B1 (fr) 2012-08-02 2016-05-20 Vitamfero Souches mutantes de neospora et leurs utilisations
FR2994096B1 (fr) 2012-08-02 2016-03-04 Vitamfero Utilisation de souches attenuees de parasites pour la prevention ou le traitement de pathologies associees a un apicomplexe

Also Published As

Publication number Publication date
CA2948845C (en) 2022-05-31
AU2015259221A1 (en) 2016-12-01
BR112016026418A2 (es) 2017-08-22
EP3142486A1 (en) 2017-03-22
US10632182B2 (en) 2020-04-28
NZ741421A (en) 2023-05-26
NZ726315A (en) 2018-04-27
AU2018203679A1 (en) 2018-06-14
WO2015175672A1 (en) 2015-11-19
US20170087230A1 (en) 2017-03-30
AU2015259221B2 (en) 2018-03-15
AU2018203679B2 (en) 2019-11-21
CA2948845A1 (en) 2015-11-19
BR112016026418A8 (pt) 2022-06-28

Similar Documents

Publication Publication Date Title
MX2016014868A (es) Metodos para secar por congelacion y rehidratar productos biologicos.
PH12017500803A1 (en) Anti-pd-1 antibodies
MX2021006931A (es) Antigenos del virus de la inmunodeficiencia humana, vectores, composiciones y metodos de uso de estos.
PH12017500022A1 (en) Carrier-antibody compositions and methods of making and using the same
PH12015501526B1 (en) Stabilized human immunodeficiency virus (hiv) envelope (env) trimer vaccines and methods of using same
PH12017500727A1 (en) Modified virus-like particles of cmv
ZA202206809B (en) Hiv vaccines comprising one or more population episensus antigens
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
MA49874A (fr) Vecteurs hvt recombinants exprimant de multiples antigènes de pathogènes aviaires, et vaccins les contenant
MX2018004598A (es) Cepas vacunales recombinantes de listeria y métodos para usar las mismas en la inmunoterapia contra el cáncer.
PH12016500500A1 (en) A viral vaccine and methods of manufacture thereof
EA201891124A3 (ru) Новые мукозные адъюванты и системы доставки
MX2013007918A (es) Peptidos inmunogenicos monomericos y multimericos.
PH12021550521A1 (en) Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
MX2014001626A (es) Preservacion asistida con vacio de productos biologicos, en particular de vacunas.
MA37749A1 (fr) Vaccins contre les virus réassortis de la fièvre catarrhale et de la peste équine
MX349657B (es) Composiciones de vacuna de matriz de proteína que incluyen policationes.
NZ725212A (en) Group a streptococcus vaccine
ZA201603187B (en) Compositions and methods vectors for inducing an enhanced immune response using poxvirus vectors
EP4316497A3 (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
PL3504225T3 (pl) Nowe antygeny białkowe otoczki ludzkiego wirusa niedoboru odporności eksprymowane przez ssaki
WO2019099578A8 (en) Use of imidazopyrimidine for modulating human immune response
MX2017011732A (es) Proteínas de fusión que comprenden glicoproteínas de la superficie del virus alfa modificado y antígeno asociado al tumor y métodos de los mismos.
WO2014140166A3 (en) Vaccine
MX2019007924A (es) Vacunas contra la influenza.